NanoVita completed a $10 million seed round of funding before the BNB token launch.

DeSci Protocol Completes Funding

NanoVita is building a health data infrastructure, which falls under the decentralized science (DeSci) track. It has just completed a funding round to support its open research platform. The project combines nanotechnology, AI, and blockchain to let users share health data and benefit from it. The DeSci protocol has some buzz in the Web3 space and is seen as another path outside traditional models of research funding and data ownership.

The funding was announced in late March 2026. Initial reports said it was a Series A, but later reports from multiple sources confirmed it was actually a seed round—there is no independent evidence supporting the existence of a Series A. The round was completed before the BNB Chain token generation event (TGE) in late April 2026.

With CGV leading the round, the participants include UNIVERSE-DIMENSIONAL SPACE (Singapore), Candaq Fintech Group, and Susie Ventures (British Virgin Islands). This round closed on March 31, 2026. K24 Ventures appeared in a social post on April 6, but it was not confirmed in the official announcement. Before token issuance, NanoVita planned to sell Alpha Pass NFT first, with rights including token airdrops, hardware (smart masks), DAO voting rights, and data contribution rewards.

NanoVita hasn’t appeared in mainstream VC databases like Crunchbase—so far, coverage has mainly come from crypto media. This is pretty common among early Web3 projects, since they haven’t yet built brand recognition outside the circle.

What Happens After Token Issuance

BNB Chain token issuance is the next big milestone. The Alpha Pass NFT gives holders an opportunity to access the network early. If the launch goes smoothly, it could bring more attention to decentralized health research data management.

• Investor composition: mainly crypto-native funds, with Asian and fintech backgrounds; CGV led the round.
• Use of funds: to build a health data platform; specific plans haven’t been published yet.
• Track status: DeSci is still niche but growing; projects like this use blockchain to improve transparency in research funding and data sharing.
• Pending verification: K24 Ventures participating was only mentioned in a single social post; other investors have more documentation supporting it.

The project’s technical description is basically consistent across multiple sources. The main issue with reporting is the confusion over whether it was a seed round or a Series A, as well as incomplete confirmation from investors—both are fairly common in early Web3 coverage. As of April 6, 2026, NanoVita is one of several DeSci projects that moved from funding announcements to the token-issuance stage.

A $10 million funding round isn’t huge, but it places NanoVita among the set of protocols aiming to reshape how health data is shared and monetized. Token issuance should help answer some unresolved questions about token economics and governance.

In the end: verification is insufficient and exposure is basically limited to crypto media, but early DeSci projects can still get funded.